Lexicon Pharmaceuticals, Inc.

CITADEL ADVISORS LLC LXRX

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/17/2026

Shares

1,710,975

Value ($000)

1,968

Weight

0.0%

2019 Q4 - 2025 Q4 (21 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/17/2026	1,968	0.0%	1,710,975	12/31/2025
2025 Q3	11/14/2025	3,556	0.0%	2,634,027	9/30/2025
2025 Q1	5/15/2025	0	0.0%	406	3/31/2025
2024 Q4	2/14/2025	19	0.0%	25,832	12/31/2024
2024 Q3	11/14/2024	155	0.0%	98,624	9/30/2024
2024 Q2	8/14/2024	4,048	0.0%	2,409,456	6/30/2024
2024 Q1	5/15/2024	323	0.0%	134,477	3/31/2024
2023 Q4	2/14/2024	1,203	0.0%	786,160	12/31/2023
2023 Q3	11/14/2023	2	0.0%	1,911	9/30/2023
2023 Q2	8/14/2023	944	0.0%	412,319	6/30/2023
2023 Q1	5/15/2023	269	0.0%	110,829	3/31/2023
2022 Q4	2/14/2023	310	0.0%	162,176	12/31/2022
2022 Q3	11/14/2022	306	0.0%	127,193	9/30/2022
2022 Q2	8/15/2022	308	0.0%	165,679	6/30/2022
2022 Q1	5/16/2022	945	0.0%	451,812	3/31/2022
2021 Q4	2/14/2022	130	0.0%	33,046	12/31/2021
2021 Q3	11/15/2021	225	0.0%	46,856	9/30/2021
2021 Q2	8/16/2021	54	0.0%	11,633	6/30/2021
2021 Q1	5/21/2021	778	0.0%	132,492	3/31/2021
2020 Q1	5/15/2020	143	0.0%	73,283	3/31/2020
2019 Q4	2/14/2020	1,323	0.0%	318,812	12/31/2019